These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29143392)

  • 21. Influenza vaccine for children.
    Neuzil KM
    Clin Infect Dis; 2004 Mar; 38(5):689-91. PubMed ID: 14986253
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
    Keitel WA; Cate TR; Nino D; Huggins LL; Six HR; Quarles JM; Couch RB
    J Infect Dis; 2001 Jan; 183(2):329-332. PubMed ID: 11110645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A one-size-fits-all flu vaccine?
    Kaiser J
    Science; 2006 Apr; 312(5772):380-2. PubMed ID: 16627732
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer.
    Halasa N; Englund JA; Nachman S; Weinberg GA; Huber VC; Allison K; Dubovsky F; Yi T; McCullers JA; Flynn PM
    Vaccine; 2011 May; 29(24):4110-5. PubMed ID: 21496468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza vaccines.
    Brede HD
    Int Arch Allergy Immunol; 1995 Dec; 108(4):318-20. PubMed ID: 7580301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiological evaluation of the protection conferred by the Nivgrip vaccine against influenza caused by the A(H1N1) virus.
    Teodorovici G; Ivan A; Petrescu A; Mihail A; Cajal N
    Virologie; 1982; 33(4):279-82. PubMed ID: 7164342
    [No Abstract]   [Full Text] [Related]  

  • 27. A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older.
    Forrest BD; Steele AD; Hiemstra L; Rappaport R; Ambrose CS; Gruber WC
    Vaccine; 2011 May; 29(20):3633-9. PubMed ID: 21440036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Characteristics of the immunological and protective effect in the simultaneous and separate use of live and killed influenza vaccines].
    Orlov VA; Zhilova GP; Smorodintsev AA; Kozhukhov VM; Ignat'eva GS
    Vopr Virusol; 1985; 30(3):280-5. PubMed ID: 4049837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reactogenicity, genetic stability and effectiveness of a live recombinant influenza vaccine for children designed on the base of a cold-adapted attenuation donor A/Leningrad/134/47/57].
    Aleksandrova GI; Medvedeva TE; Polezhaev FI; Garmashova LM; Budilovskiĭ GN
    Vopr Virusol; 1986; 31(4):411-4. PubMed ID: 2945324
    [No Abstract]   [Full Text] [Related]  

  • 30. Live attenuated influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children two to six years of age in England in the 2015/16 season.
    Pebody R; Sile B; Warburton F; Sinnathamby M; Tsang C; Zhao H; Ellis J; Andrews N
    Euro Surveill; 2017 Jan; 22(4):. PubMed ID: 28182539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct and indirect impact of influenza vaccination of young children on school absenteeism.
    King JC; Beckett D; Snyder J; Cummings GE; King BS; Magder LS
    Vaccine; 2012 Jan; 30(2):289-93. PubMed ID: 22085547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) pilot study: a cluster randomized trial.
    Kwong JC; Pereira JA; Quach S; Pellizzari R; Dusome E; Russell ML; Hamid JS; Feinberg Y; Winter AL; Gubbay JB; Sirtonski B; Moher D; Sider D; Finkelstein M; Loeb M;
    Vaccine; 2015 Jan; 33(4):535-41. PubMed ID: 25488331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The coming era of quadrivalent human influenza vaccines: who will benefit?
    Barr IG; Jelley LL
    Drugs; 2012 Dec; 72(17):2177-85. PubMed ID: 23110610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.
    Carr S; Allison KJ; Van De Velde LA; Zhang K; English EY; Iverson A; Daw NC; Howard SC; Navid F; Rodriguez-Galindo C; Yang J; Adderson EE; McCullers JA; Flynn PM
    J Infect Dis; 2011 Nov; 204(10):1475-82. PubMed ID: 21949042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The temperature sensitivity of epidemic influenza A viruses as a marker of immunogenicity of reassortant vaccinal strains].
    Kiseleva IV; Grigor'eva EP; Naĭkhin AN; Ivanova VV; Larionova NV; Donina SA; Litvinova OM; Aleksandrova GI; Rudenko LG
    Vopr Virusol; 2003; 48(4):26-9. PubMed ID: 12945203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Live influenza vaccine in the USSR: its development, study and practical use].
    Zhdanov VM; Aleksandrova GI; Gendon IuZ
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jul; (7):3-13. PubMed ID: 3529762
    [No Abstract]   [Full Text] [Related]  

  • 37. The new nasal spray influenza vaccine.
    Glezen WP
    Pediatr Infect Dis J; 2001 Aug; 20(8):731-2. PubMed ID: 11734731
    [No Abstract]   [Full Text] [Related]  

  • 38. Live attenuated intranasal influenza vaccine.
    Esposito S; Montinaro V; Groppali E; Tenconi R; Semino M; Principi N
    Hum Vaccin Immunother; 2012 Jan; 8(1):76-80. PubMed ID: 22251995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Live attenuated influenza vaccine in children.
    Ambrose CS; Walker RE; Connor EM
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibodies in human sera after vaccination with inactivated influenza vaccine.
    Loza-Tulimowska M; Semkow R; Michalak T; Wilczyński J
    Acta Virol; 1979 Mar; 23(2):159-61. PubMed ID: 39440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.